Identification of a Stat3-Dependent Transcription Regulatory Network Involved in Metastatic Progression

High levels of activated Stat3 are often found in human breast cancers and can correlate with poor patient outcome. We employed an activated ErbB2 mouse model of breast cancer to investigate the in vivo role of Stat3 in mammary tumor progression and found that Stat3 does not alter mammary tumor init...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer research (Chicago, Ill.) Ill.), 2009-09, Vol.69 (17), p.6823-6830
Hauptverfasser: RANGER, Jill J, LEVY, David E, SHAHALIZADEH, Solmaz, HALLETT, Michael, MULLER, William J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6830
container_issue 17
container_start_page 6823
container_title Cancer research (Chicago, Ill.)
container_volume 69
creator RANGER, Jill J
LEVY, David E
SHAHALIZADEH, Solmaz
HALLETT, Michael
MULLER, William J
description High levels of activated Stat3 are often found in human breast cancers and can correlate with poor patient outcome. We employed an activated ErbB2 mouse model of breast cancer to investigate the in vivo role of Stat3 in mammary tumor progression and found that Stat3 does not alter mammary tumor initiation but dramatically affects metastatic progression. Four-fold fewer animals exhibited lung metastases in the absence of Stat3 and a 12-fold reduction in the number of lung lesions was observed in animals bearing Stat3-null tumors when compared with the wild-type cohort. The decreased malignancy in Stat3-deficient tumors is attributed to a reduction in both angiogenic and inflammatory responses associated with a Stat3-dependent transcriptional cascade involving CCAAT/enhancer binding protein delta.
doi_str_mv 10.1158/0008-5472.CAN-09-1684
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2841985</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19690134</sourcerecordid><originalsourceid>FETCH-LOGICAL-c539t-897701e4d59b445ad316537de7bd017b05882c4f46816530910ccec2deb3da9c3</originalsourceid><addsrcrecordid>eNpVkMtOAyEUhonR2Hp5BA0bl6MwQAc2Jk29NanVeFkTBpiKTocGpjW-vYxtqq5OyH85hw-AE4zOMWb8AiHEM0aL_Hw0nGZIZHjA6Q7oY0Z4VlDKdkF_6-mBgxjf05NhxPZBD4uBQJjQPpiNjW1aVzmtWucb6Cuo4HOrWpJd2YVtOhW-BNVEHdzix_JkZ8tatT58waltP334gONm5euVNdA18N62KqYCp-Fj8LNgY0ypI7BXqTra4808BK831y-ju2zycDseDSeZZkS0GRdFgbClhoky_UEZggeMFMYWpUG4KBHjPNe0ogPeCUhgpLXVubElMUpocggu172LZTm3Rqfzg6rlIri5Cl_SKyf_K417kzO_kjmnWHCWCti6QAcfY7DVNouR7MjLjqrsqMpEXiIhO_Ipd_p38W9qgzoZzjYGFbWqq8RUu7j15TkmgueEfAMbn48R</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Identification of a Stat3-Dependent Transcription Regulatory Network Involved in Metastatic Progression</title><source>MEDLINE</source><source>American Association for Cancer Research</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>RANGER, Jill J ; LEVY, David E ; SHAHALIZADEH, Solmaz ; HALLETT, Michael ; MULLER, William J</creator><creatorcontrib>RANGER, Jill J ; LEVY, David E ; SHAHALIZADEH, Solmaz ; HALLETT, Michael ; MULLER, William J</creatorcontrib><description>High levels of activated Stat3 are often found in human breast cancers and can correlate with poor patient outcome. We employed an activated ErbB2 mouse model of breast cancer to investigate the in vivo role of Stat3 in mammary tumor progression and found that Stat3 does not alter mammary tumor initiation but dramatically affects metastatic progression. Four-fold fewer animals exhibited lung metastases in the absence of Stat3 and a 12-fold reduction in the number of lung lesions was observed in animals bearing Stat3-null tumors when compared with the wild-type cohort. The decreased malignancy in Stat3-deficient tumors is attributed to a reduction in both angiogenic and inflammatory responses associated with a Stat3-dependent transcriptional cascade involving CCAAT/enhancer binding protein delta.</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>DOI: 10.1158/0008-5472.CAN-09-1684</identifier><identifier>PMID: 19690134</identifier><identifier>CODEN: CNREA8</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Animals ; Antineoplastic agents ; Biological and medical sciences ; CCAAT-Enhancer-Binding Protein-delta - genetics ; CCAAT-Enhancer-Binding Protein-delta - metabolism ; Cell Transformation, Neoplastic ; Female ; Gynecology. Andrology. Obstetrics ; Humans ; Lung Neoplasms - genetics ; Lung Neoplasms - secondary ; Mammary gland diseases ; Mammary Neoplasms, Animal - genetics ; Mammary Neoplasms, Animal - pathology ; Medical sciences ; Mice ; Mice, Transgenic ; Neoplasm Invasiveness - genetics ; Neovascularization, Pathologic - genetics ; Pharmacology. Drug treatments ; Receptor, ErbB-2 - genetics ; Receptor, ErbB-2 - metabolism ; STAT3 Transcription Factor - biosynthesis ; STAT3 Transcription Factor - genetics ; Transcription, Genetic ; Tumors</subject><ispartof>Cancer research (Chicago, Ill.), 2009-09, Vol.69 (17), p.6823-6830</ispartof><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c539t-897701e4d59b445ad316537de7bd017b05882c4f46816530910ccec2deb3da9c3</citedby><cites>FETCH-LOGICAL-c539t-897701e4d59b445ad316537de7bd017b05882c4f46816530910ccec2deb3da9c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,3356,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22139823$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19690134$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>RANGER, Jill J</creatorcontrib><creatorcontrib>LEVY, David E</creatorcontrib><creatorcontrib>SHAHALIZADEH, Solmaz</creatorcontrib><creatorcontrib>HALLETT, Michael</creatorcontrib><creatorcontrib>MULLER, William J</creatorcontrib><title>Identification of a Stat3-Dependent Transcription Regulatory Network Involved in Metastatic Progression</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>High levels of activated Stat3 are often found in human breast cancers and can correlate with poor patient outcome. We employed an activated ErbB2 mouse model of breast cancer to investigate the in vivo role of Stat3 in mammary tumor progression and found that Stat3 does not alter mammary tumor initiation but dramatically affects metastatic progression. Four-fold fewer animals exhibited lung metastases in the absence of Stat3 and a 12-fold reduction in the number of lung lesions was observed in animals bearing Stat3-null tumors when compared with the wild-type cohort. The decreased malignancy in Stat3-deficient tumors is attributed to a reduction in both angiogenic and inflammatory responses associated with a Stat3-dependent transcriptional cascade involving CCAAT/enhancer binding protein delta.</description><subject>Animals</subject><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>CCAAT-Enhancer-Binding Protein-delta - genetics</subject><subject>CCAAT-Enhancer-Binding Protein-delta - metabolism</subject><subject>Cell Transformation, Neoplastic</subject><subject>Female</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Lung Neoplasms - genetics</subject><subject>Lung Neoplasms - secondary</subject><subject>Mammary gland diseases</subject><subject>Mammary Neoplasms, Animal - genetics</subject><subject>Mammary Neoplasms, Animal - pathology</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><subject>Neoplasm Invasiveness - genetics</subject><subject>Neovascularization, Pathologic - genetics</subject><subject>Pharmacology. Drug treatments</subject><subject>Receptor, ErbB-2 - genetics</subject><subject>Receptor, ErbB-2 - metabolism</subject><subject>STAT3 Transcription Factor - biosynthesis</subject><subject>STAT3 Transcription Factor - genetics</subject><subject>Transcription, Genetic</subject><subject>Tumors</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkMtOAyEUhonR2Hp5BA0bl6MwQAc2Jk29NanVeFkTBpiKTocGpjW-vYxtqq5OyH85hw-AE4zOMWb8AiHEM0aL_Hw0nGZIZHjA6Q7oY0Z4VlDKdkF_6-mBgxjf05NhxPZBD4uBQJjQPpiNjW1aVzmtWucb6Cuo4HOrWpJd2YVtOhW-BNVEHdzix_JkZ8tatT58waltP334gONm5euVNdA18N62KqYCp-Fj8LNgY0ypI7BXqTra4808BK831y-ju2zycDseDSeZZkS0GRdFgbClhoky_UEZggeMFMYWpUG4KBHjPNe0ogPeCUhgpLXVubElMUpocggu172LZTm3Rqfzg6rlIri5Cl_SKyf_K417kzO_kjmnWHCWCti6QAcfY7DVNouR7MjLjqrsqMpEXiIhO_Ipd_p38W9qgzoZzjYGFbWqq8RUu7j15TkmgueEfAMbn48R</recordid><startdate>20090901</startdate><enddate>20090901</enddate><creator>RANGER, Jill J</creator><creator>LEVY, David E</creator><creator>SHAHALIZADEH, Solmaz</creator><creator>HALLETT, Michael</creator><creator>MULLER, William J</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20090901</creationdate><title>Identification of a Stat3-Dependent Transcription Regulatory Network Involved in Metastatic Progression</title><author>RANGER, Jill J ; LEVY, David E ; SHAHALIZADEH, Solmaz ; HALLETT, Michael ; MULLER, William J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c539t-897701e4d59b445ad316537de7bd017b05882c4f46816530910ccec2deb3da9c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>CCAAT-Enhancer-Binding Protein-delta - genetics</topic><topic>CCAAT-Enhancer-Binding Protein-delta - metabolism</topic><topic>Cell Transformation, Neoplastic</topic><topic>Female</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Lung Neoplasms - genetics</topic><topic>Lung Neoplasms - secondary</topic><topic>Mammary gland diseases</topic><topic>Mammary Neoplasms, Animal - genetics</topic><topic>Mammary Neoplasms, Animal - pathology</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><topic>Neoplasm Invasiveness - genetics</topic><topic>Neovascularization, Pathologic - genetics</topic><topic>Pharmacology. Drug treatments</topic><topic>Receptor, ErbB-2 - genetics</topic><topic>Receptor, ErbB-2 - metabolism</topic><topic>STAT3 Transcription Factor - biosynthesis</topic><topic>STAT3 Transcription Factor - genetics</topic><topic>Transcription, Genetic</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>RANGER, Jill J</creatorcontrib><creatorcontrib>LEVY, David E</creatorcontrib><creatorcontrib>SHAHALIZADEH, Solmaz</creatorcontrib><creatorcontrib>HALLETT, Michael</creatorcontrib><creatorcontrib>MULLER, William J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>RANGER, Jill J</au><au>LEVY, David E</au><au>SHAHALIZADEH, Solmaz</au><au>HALLETT, Michael</au><au>MULLER, William J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification of a Stat3-Dependent Transcription Regulatory Network Involved in Metastatic Progression</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>2009-09-01</date><risdate>2009</risdate><volume>69</volume><issue>17</issue><spage>6823</spage><epage>6830</epage><pages>6823-6830</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><coden>CNREA8</coden><abstract>High levels of activated Stat3 are often found in human breast cancers and can correlate with poor patient outcome. We employed an activated ErbB2 mouse model of breast cancer to investigate the in vivo role of Stat3 in mammary tumor progression and found that Stat3 does not alter mammary tumor initiation but dramatically affects metastatic progression. Four-fold fewer animals exhibited lung metastases in the absence of Stat3 and a 12-fold reduction in the number of lung lesions was observed in animals bearing Stat3-null tumors when compared with the wild-type cohort. The decreased malignancy in Stat3-deficient tumors is attributed to a reduction in both angiogenic and inflammatory responses associated with a Stat3-dependent transcriptional cascade involving CCAAT/enhancer binding protein delta.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>19690134</pmid><doi>10.1158/0008-5472.CAN-09-1684</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0008-5472
ispartof Cancer research (Chicago, Ill.), 2009-09, Vol.69 (17), p.6823-6830
issn 0008-5472
1538-7445
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2841985
source MEDLINE; American Association for Cancer Research; EZB-FREE-00999 freely available EZB journals
subjects Animals
Antineoplastic agents
Biological and medical sciences
CCAAT-Enhancer-Binding Protein-delta - genetics
CCAAT-Enhancer-Binding Protein-delta - metabolism
Cell Transformation, Neoplastic
Female
Gynecology. Andrology. Obstetrics
Humans
Lung Neoplasms - genetics
Lung Neoplasms - secondary
Mammary gland diseases
Mammary Neoplasms, Animal - genetics
Mammary Neoplasms, Animal - pathology
Medical sciences
Mice
Mice, Transgenic
Neoplasm Invasiveness - genetics
Neovascularization, Pathologic - genetics
Pharmacology. Drug treatments
Receptor, ErbB-2 - genetics
Receptor, ErbB-2 - metabolism
STAT3 Transcription Factor - biosynthesis
STAT3 Transcription Factor - genetics
Transcription, Genetic
Tumors
title Identification of a Stat3-Dependent Transcription Regulatory Network Involved in Metastatic Progression
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T22%3A36%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20of%20a%20Stat3-Dependent%20Transcription%20Regulatory%20Network%20Involved%20in%20Metastatic%20Progression&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=RANGER,%20Jill%20J&rft.date=2009-09-01&rft.volume=69&rft.issue=17&rft.spage=6823&rft.epage=6830&rft.pages=6823-6830&rft.issn=0008-5472&rft.eissn=1538-7445&rft.coden=CNREA8&rft_id=info:doi/10.1158/0008-5472.CAN-09-1684&rft_dat=%3Cpubmed_cross%3E19690134%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/19690134&rfr_iscdi=true